
Lilly’s Donanemab: The 3rd New Alzheimer’s Drug
Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.
Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.
Doctors routinely diagnose and track dementia. “Neuropsychological tests” are non-invasive, using interviews or paper/pen tests. More invasive diagnostics include powerful MRI and PET scans.
The new Alzheimer’s injections Aduhelm and Lecanemab offer hope. Now, Mastinimab is trying to break through to the next level with a simpler pill. Mastinimab fights Alzheimer’s via a revolutionary mechanism of action. Learn why the FDA approved Mastinimab’s final round of trials.
CLINICAL TRIALS VIDEO: Thin electrical wires were surgically implanted in the brain of Alzheimer’s patients. Called “Deep Brain Stimulation”, see how this brain “pacemaker” improves
VIDEO + ARTICLE: An award-winning director joins the nation’s largest independent registered investment advisory firm to film a documentary on clinical trials by diet guru
Anticholinergic drugs have been consistently linked to cognitive impairment. Scientists seek de-prescribing trials to test anticholinergic drugs as reversible risk factors for dementia. Can de-prescribing
VIDEO + ARTICLE: A blood test to detect Alzheimer’s has moved one step closer to reality. Washington University can measure Alzheimer’s proteins in the blood
126 DRUGS ARE IN ALZHEIMER’S clinical trials. “Every single one represents hope,” according to Closing in on a Cure: Alzheimer’s Clinical Trials Report. Read the
In the lab, fujimycin slowed Alzheimer’s. (Fujimycin is an organ-transplant drug also called FK506 or Tacrolimus.) In past studies, similar drugs, like rapamycin and ciclosporin,
DRUG RESEARCH VIDEO + ARTICLE: This FDA-approved anti-epileptic medication benefits Alzheimer’s in the lab. Learn about the promising research.
M.I.T.’s Rendever takes dementia residents like Miriam Keith back to wonderful places no longer accessible to them.
Teepa Snow is the best of all the recognized experts on how to work with dementia patients. See her demonstrate how to engage people in early and mid-stage Alzheimer’s.
Studies have found an association between hearing loss and the development of dementia in older adults. Research also suggests that using hearing aids to treat hearing loss may help slow the development of cognitive problems.
GUEST POST: Calendar Clock assists caregivers and people with dementia with their daily schedule. This reduces disorientation in time and the frustration it can cause. Additionally, it offers monitoring capabilities, via its appointments feature and video calling. This all provides a sense of security for everyone, both caregiver and care-receiver. It is a free application co-created by many real-world users.
M.I.T.’s Rendever takes dementia residents like Miriam Keith back to wonderful places no longer accessible to them.
Teepa Snow is the best of all the recognized experts on how to work with dementia patients. See her demonstrate how to engage people in early and mid-stage Alzheimer’s.
It’s normal to forget things once in a while as the years pass, but how can you tell whether those memory lapses are a sign of something more serious — like Alzheimer’s?
Melvyn Amrine may not have remembered the details of his life since his Alzheimer’s diagnosis, but he sure proved that his love for his wife transcended memory.
No spam, only news and updates.